A new publication involving AOD-9604 was released on April 12, 2026. The article, titled "Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance," appeared in the journal Sports Medicine (Auckland, N.Z.).
The publication is listed under PubMed ID 41966639. It addresses both approved and unapproved peptide therapies in the context of musculoskeletal injuries and athletic performance, according to its title.
AOD-9604 remains classified as an unapproved compound used in research settings. No specific findings, outcomes, or conclusions from the publication have been provided beyond its title, journal, and publication date.
This brief reports only that the publication exists and covers the stated topic area. No claims about efficacy, safety outcomes, or comparative results can be drawn from the information available at this time.
Readers interested in additional background may consult the AOD-9604 compound overview for further context.